428 related articles for article (PubMed ID: 27054879)
21. Protection of chickens against H5N1 highly pathogenic avian influenza virus infection by live vaccination with infectious laryngotracheitis virus recombinants expressing H5 hemagglutinin and N1 neuraminidase.
Pavlova SP; Veits J; Keil GM; Mettenleiter TC; Fuchs W
Vaccine; 2009 Jan; 27(5):773-85. PubMed ID: 19041677
[TBL] [Abstract][Full Text] [Related]
22. Generation of an attenuated H5N1 avian influenza virus vaccine with all eight genes from avian viruses.
Shi H; Liu XF; Zhang X; Chen S; Sun L; Lu J
Vaccine; 2007 Oct; 25(42):7379-84. PubMed ID: 17870216
[TBL] [Abstract][Full Text] [Related]
23. Immunization with influenza A virus hemagglutinin and neuraminidase produced in recombinant baculovirus results in a balanced and broadened immune response superior to conventional vaccine.
Johansson BE
Vaccine; 1999 Apr; 17(15-16):2073-80. PubMed ID: 10217609
[TBL] [Abstract][Full Text] [Related]
24. Comparative efficacy of North American and antigenically matched reverse genetics derived H5N9 DIVA marker vaccines against highly pathogenic Asian H5N1 avian influenza viruses in chickens.
Jadhao SJ; Lee CW; Sylte M; Suarez DL
Vaccine; 2009 Oct; 27(44):6247-60. PubMed ID: 19686695
[TBL] [Abstract][Full Text] [Related]
25. Neuraminidase inhibitor-resistant recombinant A/Vietnam/1203/04 (H5N1) influenza viruses retain their replication efficiency and pathogenicity in vitro and in vivo.
Yen HL; Ilyushina NA; Salomon R; Hoffmann E; Webster RG; Govorkova EA
J Virol; 2007 Nov; 81(22):12418-26. PubMed ID: 17855542
[TBL] [Abstract][Full Text] [Related]
26. Neuraminidase amino acids 149 and 347 determine the infectivity and oseltamivir sensitivity of pandemic influenza A/H1N1 (2009) and avian influenza A/H5N1.
Yongkiettrakul S; Nivitchanyong T; Pannengpetch S; Wanitchang A; Jongkaewwattana A; Srimanote P
Virus Res; 2013 Aug; 175(2):128-33. PubMed ID: 23639424
[TBL] [Abstract][Full Text] [Related]
27. Comparison of neuraminidase activity of influenza A virus subtype H5N1 and H1N1 using reverse genetics virus.
Rawangkhan A; Sanguansermsri D; Suwannakhon N; Pongcharoen S; Pensuwan P; Chamnanpood C; Chamnanpood P; Sanguansermsri P
Southeast Asian J Trop Med Public Health; 2010 May; 41(3):562-9. PubMed ID: 20578543
[TBL] [Abstract][Full Text] [Related]
28. H5N1 virus-like particle vaccine elicits cross-reactive neutralizing antibodies that preferentially bind to the oligomeric form of influenza virus hemagglutinin in humans.
Khurana S; Wu J; Verma N; Verma S; Raghunandan R; Manischewitz J; King LR; Kpamegan E; Pincus S; Smith G; Glenn G; Golding H
J Virol; 2011 Nov; 85(21):10945-54. PubMed ID: 21865396
[TBL] [Abstract][Full Text] [Related]
29. Virus-like particle vaccine comprised of the HA, NA, and M1 proteins of an avian isolated H5N1 influenza virus induces protective immunity against homologous and heterologous strains in mice.
Tao P; Luo M; Zhu D; Qu S; Yang Z; Gao M; Guo D; Pan Z
Viral Immunol; 2009 Jul; 22(4):273-81. PubMed ID: 19594398
[TBL] [Abstract][Full Text] [Related]
30. An influenza N1 neuraminidase-specific monoclonal antibody with broad neuraminidase inhibition activity against H5N1 HPAI viruses.
Shoji Y; Chichester JA; Palmer GA; Farrance CE; Stevens R; Stewart M; Goldschmidt L; Deyde V; Gubareva L; Klimov A; Mett V; Yusibov V
Hum Vaccin; 2011; 7 Suppl():199-204. PubMed ID: 21922687
[TBL] [Abstract][Full Text] [Related]
31. H5N1 hybrid viruses bearing 2009/H1N1 virus genes transmit in guinea pigs by respiratory droplet.
Zhang Y; Zhang Q; Kong H; Jiang Y; Gao Y; Deng G; Shi J; Tian G; Liu L; Liu J; Guan Y; Bu Z; Chen H
Science; 2013 Jun; 340(6139):1459-63. PubMed ID: 23641061
[TBL] [Abstract][Full Text] [Related]
32. Cross-protective immunity against multiple influenza virus subtypes by a novel modified vaccinia Ankara (MVA) vectored vaccine in mice.
Brewoo JN; Powell TD; Jones JC; Gundlach NA; Young GR; Chu H; Das SC; Partidos CD; Stinchcomb DT; Osorio JE
Vaccine; 2013 Apr; 31(14):1848-55. PubMed ID: 23376279
[TBL] [Abstract][Full Text] [Related]
33. Identification of critical residues in the hemagglutinin and neuraminidase of influenza virus H1N1pdm for vaccine virus replication in embryonated chicken eggs.
Wang W; Lu J; Cotter CR; Wen K; Jin H; Chen Z
J Virol; 2013 Apr; 87(8):4642-9. PubMed ID: 23408613
[TBL] [Abstract][Full Text] [Related]
34. Influenza M1 VLPs containing neuraminidase induce heterosubtypic cross-protection.
Quan FS; Kim MC; Lee BJ; Song JM; Compans RW; Kang SM
Virology; 2012 Sep; 430(2):127-35. PubMed ID: 22658901
[TBL] [Abstract][Full Text] [Related]
35. Multi-Influenza HA Subtype Protection of Ferrets Vaccinated with an N1 COBRA-Based Neuraminidase.
Skarlupka AL; Zhang X; Blas-Machado U; Sumner SF; Ross TM
Viruses; 2023 Jan; 15(1):. PubMed ID: 36680224
[TBL] [Abstract][Full Text] [Related]
36. A novel bivalent vaccine based on a PB2-knockout influenza virus protects mice from pandemic H1N1 and highly pathogenic H5N1 virus challenges.
Uraki R; Kiso M; Iwatsuki-Horimoto K; Fukuyama S; Takashita E; Ozawa M; Kawaoka Y
J Virol; 2013 Jul; 87(14):7874-81. PubMed ID: 23658445
[TBL] [Abstract][Full Text] [Related]
37. Cloned cDNA of A/swine/Iowa/15/1930 internal genes as a candidate backbone for reverse genetics vaccine against influenza A viruses.
Lekcharoensuk P; Wiriyarat W; Petcharat N; Lekcharoensuk C; Auewarakul P; Richt JA
Vaccine; 2012 Feb; 30(8):1453-9. PubMed ID: 22230579
[TBL] [Abstract][Full Text] [Related]
38. Deliberate reduction of hemagglutinin and neuraminidase expression of influenza virus leads to an ultraprotective live vaccine in mice.
Yang C; Skiena S; Futcher B; Mueller S; Wimmer E
Proc Natl Acad Sci U S A; 2013 Jun; 110(23):9481-6. PubMed ID: 23690603
[TBL] [Abstract][Full Text] [Related]
39. Mechanisms of the action of povidone-iodine against human and avian influenza A viruses: its effects on hemagglutination and sialidase activities.
Sriwilaijaroen N; Wilairat P; Hiramatsu H; Takahashi T; Suzuki T; Ito M; Ito Y; Tashiro M; Suzuki Y
Virol J; 2009 Aug; 6():124. PubMed ID: 19678928
[TBL] [Abstract][Full Text] [Related]
40. In vitro and in vivo efficacy of fluorodeoxycytidine analogs against highly pathogenic avian influenza H5N1, seasonal, and pandemic H1N1 virus infections.
Kumaki Y; Day CW; Smee DF; Morrey JD; Barnard DL
Antiviral Res; 2011 Nov; 92(2):329-40. PubMed ID: 21925541
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
